Breaking Finance News

OMNOVA Solutions Inc. (NYSE:OMN) has been downgraded to Hold in a report by Zacks Investment Research earlier today.

Just yesterday OMNOVA Solutions Inc. (NYSE:OMN) traded -4.66% lower at $8.19. OMN’s 50-day average is $9.58 and its two hundred day average is $7.72. With the last close up 6.11% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 717,360 shares of the stock were exchanged, up from an average trading volume of 366,544

Zacks Investment Research has downgraded OMNOVA Solutions Inc. (NYSE:OMN) to Hold in a statement released on 9/24/2016.

Previously on 1/23/2014, Jefferies & Co reported on OMNOVA Solutions Inc. (NYSE:OMN) upped the target price from $10.00 to $11.00 that suggested an upside of 1.10%.

See Chart Below

OMNOVA Solutions Inc. (NYSE:OMN)

OMNOVA Solutions Inc. has with a one year low of $4.37 and a 52 week high of $10.42 and has a market cap of $0.

About OMNOVA Solutions Inc. (NYSE:OMN)

OMNOVA Solutions Inc. (OMNOVA) is a provider of emulsion polymers, specialty chemicals and engineered surfaces for commercial, industrial and residential end uses. The Company operates in two segments: Performance Chemicals and Engineered Surfaces. OMNOVA Performance Chemicals segment produces a range of emulsion polymers and specialty chemicals based primarily on styrene butadiene (SB), styrene butadiene acrylonitrile (SBA), styrene butadiene vinyl pyridine, nitrile butadiene (NBR), polyvinyl acetate, acrylic, styrene acrylic, vinyl acrylic, glyoxal, fluorochemical and bio-based chemistries. The Company's Engineered Surfaces segment develops, designs, produces and markets a line of functional and decorative surfacing products, including coated fabrics, vinyl, paper and specialty laminates, and performance films. It operates production facilities in the United States, Europe, China and India.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *